October 9, 2018
- FDA Drug Shortages
- Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (Updated - Currently in Shortage)
- Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (Updated - Currently in Shortage)
- First Generic Drug Approvals (updated)
- Product-Specific Guidances for Generic Drug Development (updated, 2 new guidances, 23 revisions)
- Assessing Adhesion with Transdermal Delivery Systems and Topical Patches for ANDAs Draft Guidance for Industry (PDF - 187KB)
- Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs Guidance for Industry (PDF - 235KB)
.png)
No hay comentarios:
Publicar un comentario